Cover Image
市場調查報告書

亞太地區醫療保健市場前景:2018年

Asia-Pacific Healthcare Outlook, 2018

出版商 Frost & Sullivan 商品編碼 356950
出版日期 內容資訊 英文 113 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞太地區醫療保健市場前景:2018年 Asia-Pacific Healthcare Outlook, 2018
出版日期: 2018年04月03日 內容資訊: 英文 113 Pages
簡介

亞太地區 (APAC) 的醫療保健行業預計在2018年將成長11.1%。技術的引進推廣、創新的醫療保健准入計畫,及在傳統醫院以外提供的護理,促進了正面成長。亞太地區的醫療保健市場預計在2018年將增加到5170億美元。

本報告調查了亞太地區的醫療保健市場,提供世界醫療保健產業概要、亞太地區醫療保健產業主要動態、成長機會、預測及不同部分及國家的動態與預測等。

第1章 執行摘要

第2章 世界醫療保健行業概況

  • 全球醫療保健收入:依不同部門
  • 全球醫療保健市場預測

第3章 亞太地區醫療保健產業展望與預測

  • APAC總收入
  • APAC受矚目的主要國家
  • APAC在2018年面臨340萬床位短缺:估計這個數字在2022年將急速增加至360萬床
  • 預估在2018年,區域整體將會有超過200萬人首次加入民間醫療保險
  • 來自中國和印度的出境醫療旅遊在2018年年底估計將成長至200萬人以上
  • 家庭監測平台、家庭護理服務,在2018年顯示有5億700萬美元的商機、其他

第4章 亞太地區全體醫療保健產業的顯著動態

  • 由於癌症治療成本高達6位數,企業被迫轉向以研究成果為本的契約
  • 量身打造與消費者賦權的結合,成為預防保健的主要因素
  • 政府對醫療設備上限價格的關注,在數個APAC國家打開了新的可能性、其他

第5章 亞太地區醫療保健產業的成長機會

  • 亞太地區醫療保健產業的成長機會
  • 重要的成功因素

第6章 醫藥品與生物科技的主要趨勢

  • 醫藥品與生物科技的動態
  • 醫藥品與生物科技的收益
  • 受矚目的醫藥品與生物科技企業

第7章 體外診斷的主要趨勢

  • 體外診斷的趨勢
  • 體外診斷的收益
  • 受矚目的體外診斷企業

第8章 醫療技術、醫學影像的主要趨勢

  • 醫療技術的趨勢
  • 醫學影像的趨勢
  • 醫療技術的收益
  • 醫學影像的收益
  • 受矚目的醫療技術企業

第9章 數位保健的主要趨勢

  • 數位保健趨勢
  • 數位保健收益
  • 受矚目的數位保健企業

第10章 醫療保健服務的主要趨勢

  • 醫療保健服務的趨勢
  • 醫療保健服務市場規模
  • 受矚目的醫療保健服務企業

第11章 亞太地區各國概要

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 紐西蘭
  • 菲律賓
  • 新加坡
  • 韓國
  • 臺灣
  • 泰國
  • 越南

第12章 結論

第13章 附錄

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: P9E1-48

The Year of Digital Innovation in Asia-Pacific

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 11.1% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care outside traditional hospital settings. Frost & Sullivan projects the APAC healthcare market to grow to $517 billion in 2018. For the region, healthcare challenges of access and affordability of new technology demand complex and innovative solutions from all industry stakeholders. Key industry issues that deserve attention include policy innovation, support for new business models, development of patient-focused technology platforms, and the evolving role of consumers in healthcare. These emerging trends create growth opportunities for industry participants including pharmaceuticals, diagnostics, and medical technology manufacturers, digital health vendors, and healthcare service providers.

The role of healthcare consumers is changing dramatically in APAC. Digital technology is enabling access to information and care; hence consumers are able to choose where, how, and by whom they would like to be treated. This is changing every business model in the region. With this major industry transition as the background, some of the Growth Opportunities discussed in this year's Outlook cover the following areas:

  • Private Health Insurance
  • Medical Tourism
  • Healthcare Provider Infrastructure
  • Imaging Analytics
  • Patient Monitoring Platforms
  • Mental Health
  • Regenerative Medicine
  • Biosimilars
  • Cloud and AI.

An important global trend that is currently missing in APAC is the introduction of value- and outcomes-based payment and reimbursement models. Industry suppliers, including IT vendors, medical technology companies and pharmaceuticals, are partnering with public and private payers to introduce outcomes-based reimbursement models for expensive therapeutic products and services in other parts of the world. In 2018, Japan could be the first in APAC to introduce an outcomes-based reimbursement model for Novartis' CAR-T therapy, with China potentially following suit. On the other hand, personalization combined with consumer empowerment will be the key ingredient for disease prevention and patient wellness. Direct-to-consumer gene sequencing is moving toward services and solutions as companies like Prudential, iCarbonX, and Healthi have introduced personalized wellness interventions. On the other hand, companies like Thorne Research and Imagene Labs will make available personalized over-the-counter nutritional supplements and skin care products, respectively, and that too on a subscription model.

In a nutshell, 2018 is expected to be the year when APAC truly transforms industry business models, with technology and data transparency being the key enablers. Our outlook discusses the qualitative and quantitative factors driving this transformation.

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings-Asia-Pacific Healthcare Market Snapshot
  • 2018 Predictions for the Asia-Pacific Healthcare Industry
  • Growth Opportunities in Asia-Pacific Healthcare Industry
  • Growth Opportunities in Asia-Pacific Healthcare Industry (continued)
  • Growth Opportunities in Asia-Pacific Healthcare Industry (continued)
  • Critical Success Factors
  • Scope and Segmentation
  • Key Questions this Study will Answer

2. 2018 GLOBAL HEALTHCARE INDUSTRY SNAPSHOT

  • Global Healthcare Revenues by Sector in 2017 and 2018
  • Key 2018 Healthcare Market Predictions
  • Key 2018 Healthcare Market Predictions (continued)

3. 2018 ASIA-PACIFIC HEALTHCARE INDUSTRY OUTLOOK AND PREDICTIONS

  • Total APAC Revenue
  • Key APAC Countries to Watch
  • APAC will Face a Shortage of 3.4 Million Beds in 2018; This Number is Expected to Surge to 3.6 Million By 2022
  • Over 2 Million New People Across the Region will Buy Private Health Insurance in 2018
  • Outbound Medical Tourism from China and India will Grow to Over 2 Million Travellers by the End of 2018
  • Home Monitoring Platforms and Homecare Services Represent an Opportunity Worth $507 Million in 2018
  • Fast-tracking Innovative Therapeutic Products will Reduce Time-to-market to Less than 6 Months; China in the Lead
  • Mental Health will Emerge as a Key Area of Focus with a Potential Patient Base of Over 344 Million in 2018
  • Biomarkers Market in APAC will Grow at 17.4% in 2018
  • Digital Platforms will Drive 20% Growth in the Clinical Trials Market, Hitting Revenue of Over $10 Billion

4. NOTABLE TRENDS TO HIGHLIGHT FOR 2018 ACROSS THE ASIA-PACIFIC HEALTHCARE INDUSTRY

  • Six-digit Treatment Costs in Oncology will Compel Companies to Move Toward Outcome-based Contracts
  • Personalization Combined with Consumer Empowerment will be the Key Ingredient for Prevention and Wellness
  • Government Focus on Price Caps on Medical Devices will Open Up New Possibilities in Some APAC Countries
  • Regional Regulatory Reforms and Business Transformations will Propel Further ASEAN Harmonization

5. GROWTH OPPORTUNITIES IN THE ASIA-PACIFIC HEALTHCARE INDUSTRY IN 2018

  • Growth Opportunities in Asia-Pacific Healthcare Industry
  • Growth Opportunities in Asia-Pacific Healthcare Industry (continued)
  • Growth Opportunities in Asia-Pacific Healthcare Industry (continued)
  • Critical Success Factors

6. TOP TRENDS IN PHARMACEUTICALS & BIOTECHNOLOGY

  • Pharmaceutical & Biotechnology Trends
  • Pharmaceutical & Biotechnology Trends (continued)
  • Pharmaceutical & Biotechnology Revenues
  • Pharmaceutical & Biotechnology Companies to Watch in 2018

7. TOP TRENDS IN IN-VITRO DIAGNOSTICS

  • In-Vitro Diagnostics Trends
  • In-Vitro Diagnostics Trends (continued)
  • In-Vitro Diagnostics Revenues
  • In-Vitro Diagnostics Revenues (continued)
  • In-Vitro Diagnostics Companies to Watch in 2018

8. TOP TRENDS IN MEDICAL TECHNOLOGIES & MEDICAL IMAGING

  • Medical Technology Trends
  • Medical Technology Trends (continued)
  • Medical Imaging Trends
  • Medical Imaging Trends (continued)
  • Medical Technologies Revenues
  • Medical Imaging Revenues
  • Medical Technology Companies to Watch in 2018

9. TOP TRENDS IN DIGITAL HEALTH

  • Digital Health Trends
  • Digital Health Trends (continued)
  • Digital Health Revenues
  • Digital Health Companies to Watch in 2018

10. TOP TRENDS IN HEALTHCARE SERVICES

  • Healthcare Services Trends
  • Healthcare Services Trends (continued)
  • Healthcare Services Trends (continued)
  • Healthcare Services Market Size
  • Healthcare Services Companies to Watch in 2018

11. ASIA-PACIFIC COUNTRY SNAPSHOTS

  • Spotlight Australia
  • Spotlight China
  • Spotlight India
  • Spotlight Indonesia
  • Spotlight Japan
  • Spotlight Malaysia
  • Spotlight New Zealand
  • Spotlight Philippines
  • Spotlight Singapore
  • Spotlight South Korea
  • Spotlight Taiwan
  • Spotlight Thailand
  • Spotlight Vietnam

12. CONCLUSION

  • Conclusions
  • Legal Disclaimer

13. APPENDIX I-INDUSTRY REGULATORY TRANSITIONS, M&AS AND PARTNERSHIPS

  • Major Regulatory Transitions Impacting Pharmaceuticals & Biotechnology
  • Major Regulatory Transitions Impacting Pharmaceuticals & Biotechnology (continued)
  • Key Industry Partnerships Impacting Pharmaceuticals & Biotechnology
  • Major Regulatory Transitions Impacting In-Vitro Diagnostics
  • Key Industry Partnerships Impacting In-Vitro Diagnostics
  • Major Regulatory Transitions Impacting Medical Technologies and Medical Imaging
  • Key Industry Partnerships Impacting Medical Technologies and Medical Imaging
  • Major Regulatory Transitions Impacting Digital Health
  • Major Regulatory Transitions Impacting Digital Health (continued)
  • Key Industry Partnerships Impacting Digital Health
  • Key Industry Partnerships Impacting Digital Health (continued)
  • Key Industry Partnerships Impacting Digital Health (continued)
  • Key Industry Partnerships Impacting Digital Health (continued)
  • Key Industry Partnerships Impacting Digital Health (continued)
  • Major Regulatory Transitions Impacting Healthcare Services
  • Major Regulatory Transitions Impacting Healthcare Services (continued)
  • Major Regulatory Transitions Impacting Healthcare Services (continued)
  • Key Industry Partnerships Impacting Healthcare Services
  • Key Industry Partnerships Impacting Healthcare Services (continued)
  • Key Industry Partnerships Impacting Healthcare Services (continued)

14. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
Back to Top